Jacek J. Litewka
Krakow, MA, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
BCL2 inhibition in acute and chronic pancreatitis - is there a therapeutic perspective?
Journal: Cell death discovery
Published: January 27, 2026
Novel 1,3,5-triazine-based TRPA1 activators alleviate pro-fibrotic response in human lung fibroblasts.
Journal: European journal of pharmacology
Published: January 02, 2026
VDAC1 as Janus in cell death and survival: Annexin A5 to the rescue.
Journal: Cell calcium
Published: July 01, 2025
Biophysical and biochemical signatures of pancreatic stellate cell activation: insights into mechano-metabolic signalling from atomic force microscopy and Raman spectroscopy.
Journal: Cell communication and signaling : CCS
Published: May 01, 2025
Repurposing BCL2 inhibitors: Venetoclax protects against acinar cell necrosis in acute pancreatitis by promoting apoptosis.
Journal: Cell death & disease
Published: September 19, 2024
Polyethylene Glycols Stimulate Ca2+ Signaling, Cytokine Production, and the Formation of Neutrophil Extracellular Traps.
Journal: International journal of nanomedicine
Published: July 25, 2024
Driver Mutations of Pancreatic Cancer Affect Ca2+ Signaling and ATP Production.
Journal: Function (Oxford, England)
Published: May 23, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026